Erratum: Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial (The Lancet (2017) 389(10085) (2214–2225) (S0140673617306475) (10.1016/S0140-6736(17)30647-5));Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial

The Lancet

Volumn 389, Issue 10085, 2017, Pages 2214-2225

  Ahern, Amy L ^a,b   Wheeler, Graham M ^b,c   Aveyard, Paul ^d   Boyland, Emma J ^e   Halford, Jason C G ^e   Mander, Adrian P ^b   Woolston, Jennifer ^a   Thomson, Ann M ^a   Tsiountsioura, Melina ^a   Cole, Darren ^a   Mead, Bethan R ^e   Irvine, Lisa ^f   Turner, David ^f   Suhrcke, Marc ^f,g   Pimpin, Laura ^h   Retat, Lise ^h   Jaccard, Abbygail ^h   Webber, Laura ^h   Cohn, Simon R ⁱ   Jebb, Susan A ^a,d  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g UNIVERSITY OF YORK   (United Kingdom)

^h UK Health Forum   (United Kingdom)

ⁱ LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WEIGHT LOSS PROGRAM; AGED; BEHAVIOR THERAPY; BODY WEIGHT LOSS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; ENGLAND; HEALTH CARE COST; MALE; MIDDLE AGED; NATIONAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; QUALITY OF LIFE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; AGED; BEHAVIOR THERAPY; BODY WEIGHT; COST-BENEFIT ANALYSIS; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OBESITY; PRIMARY HEALTH CARE; QUALITY OF LIFE; REFERRAL AND CONSULTATION; SOCIOECONOMIC FACTORS; STATE MEDICINE; TIME FACTORS; WEIGHT LOSS; WEIGHT REDUCTION PROGRAMS;

EID: 85018987942     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31257-6     Document Type: Erratum

References (35)

1. Ng, M, Fleming, T, Robinson, M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
2. Stevens, G, Global health risks: progress and challenges. Bull World Health Organ, 87, 2009, 646.
3. Hartmann-Boyce, J, Johns, DJ, Jebb, SA, Summerbell, C, Aveyard, P, for the Behavioural Weight Management Review Group. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis. Obes Rev 15 (2014), 920–932.
4. National Instiute of Health and Clinical Excellence. Managing overweight and obesity in adults: lifestyle weight management services (NICE Guidance PH53). https://www.nice.org.uk/guidance/ph53, 2014 (accessed March 16, 2017).
5. Public Health England. National mapping of weight management services: provision of tier 2 and tier 3 services in England. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/484115/Final_Weight_Management_Mapping_Report.pdf, December, 2015 (accessed March 16, 2017).
6. Hartmann-Boyce, J, Johns, DJ, Jebb, SA, Aveyard, P, for the Behavioural Weight Management Review Group. Effect of behavioural techniques and delivery mode on effectiveness of weight management: systematic review, meta-analysis and meta-regression. Obes Rev 15 (2014), 598–609.
7. Ross Middleton, KM, Patidar, SM, Perri, MG, The impact of extended care on the long-term maintenance of weight loss: a systematic review and meta-analysis. Obes Rev 13 (2012), 509–517.
8. Fuller, NR, Colagiuri, S, Schofield, D, et al. A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care–an international randomised controlled trial. Int J Obes 37 (2013), 828–834.
9. Ahern, AL, Aveyard, PN, Halford, JC, et al. Weight loss referrals for adults in primary care (WRAP): protocol for a multi-centre randomised controlled trial comparing the clinical and cost-effectiveness of primary care referral to a commercial weight loss provider for 12 weeks, referral for 52 week. BMC Public Health, 14, 2014, 620.
10. British Heart Foundation. So you want to lose weight…for good. https://www.bhf.org.uk/publications/large-print/so-you-want-to-lose-weight-for-good–-large-print, May, 2005 (accessed March 16, 2017).
11. Brooks, R, EuroQol: the current state of play. Health Policy 37 (1996), 53–72.
12. Dolan, P, Gudex, C, Kind, P, Williams, A, A social tariff for EuroQol: results from a UK general population survey. http://ideas.repec.org/p/chy/respap/138chedp.html, 1995 (accessed March 16, 2017).
13. Jebb, SA, Ahern, AL, Olson, AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 378 (2011), 1485–1492.
14. Jolly, K, Lewis, A, Beach, J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ, 343, 2011, d6500.
15. Ridyard, CH, Hughes, DA, Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment program. Value Health 13 (2010), 867–872.
16. Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, BJ, Stoddart, GL, Methods for the economic evaluation of health care programmes, 3rd edn., 2005, Oxford University Press, Oxford http://econpapers.repec.org/RePEc:oxp:obooks:9780198529453 (accessed March 16, 2017).
17. McPherson, K, Marsh, T, Brown, M, Tackling obesities: future choices—modelling future trends in obesity and their impact on health. https://www.gov.uk/government/publications/reducing-obesity-modelling-future-trends, Oct 17, 2007 (accessed March 16, 2017).
18. Butland, B, Jebb, S, Kopelman, P, et al. Tackling obesities: future choices—project report. https://www.gov.uk/government/collections/tackling-obesities-future-choices#project-report, 2007 (accessed March 16, 2017).
19. NatCen Social Research. Health Survey for England 2003–2016. UK Data Service. https://discover.ukdataservice.ac.uk/series/?sn=2000021 (accessed March 16, 2017).
20. Zomer, E, Gurusamy, K, Leach, R, et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 17 (2016), 1001–1011.
21. Ahern, AL, Olson, AD, Aston, LM, Jebb, SA, Weight Watchers on prescription: an observational study of weight change among adults referred to Weight Watchers by the NHS. BMC Public Health, 11, 2011, 434.
22. Office for National Statistics. Population estimates for UK, England and Wales, Scotland and Northern Ireland, mid 2015. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/annualmidyearpopulationestimates/mid2015, June 23, 2016 (accessed March 16, 2017).
23. Ahern, AL, Aveyard, P, Boyland, EJ, Halford, JCG, Jebb, SA, Inequalities in the uptake of weight management interventions in a pragmatic trial: an observational study in primary care. Br J Gen Pract 66 (2016), e258–e263.
24. Hunt, K, Gray, CM, Maclean, A, Smillie, S, Bunn, C, Wyke, S, Do weight management programmes delivered at professional football clubs attract and engage high risk men? A mixed-methods study. BMC Public Health, 14, 2014, 50.
25. Capewell, S, Graham, H, Will cardiovascular disease prevention widen health inequalities?. PLoS Med, 7, 2010, e1000320.
26. Elobeid, MA, Padilla, MA, McVie, T, et al. Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One, 4, 2009, e6624.
27. Gudzune, KA, Doshi, RS, Mehta, AK, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med 162 (2015), 501–512.
28. Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
29. Hernan, WH, Brandle, M, Zhang, P, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26 (2003), 36–47.
30. DPP Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 3 (2015), 866–875.
31. Allen, JT, Cohn, SR, Ahern, AL, Experiences of a commercial weight-loss programme after primary care referral: a qualitative study. Br J Gen Pract 65 (2015), e248–e255.
32. Aveyard, P, Lewis, A, Tearne, S, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet 388 (2016), 2492–2500.
33. Hartmann-Boyce, J, Jebb, SA, Fletcher, BR, Aveyard, P, Self-help for weight loss in overweight and obese adults: systematic review and meta-analysis. Am J Public Health 105 (2015), e43–e57.
34. Johns, DJ, Hartmann-Boyce, J, Jebb, SA, Aveyard, P, for the Behavioural Weight Management Review Group. Weight change among people randomized to minimal intervention control groups in weight loss trials. Obesity 24 (2016), 772–780.
35. Anderson, AS, Craigie, AM, Caswell, S, et al. The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial. BMJ, 348, 2014, g1823.